Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2025-12-25 @ 3:30 PM
Study NCT ID:
NCT04211168
Status:
UNKNOWN
Last Update Posted:
2023-03-29
First Post:
2019-12-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers
Sponsor:
Peking Union Medical College Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2019-12-22
First Submit QC Date:
None
Study First Post Date:
2019-12-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-27
Last Update Post Date:
2023-03-29
Last Update Post Date Type:
ACTUAL